Chiropractors in Ashland, WI Accepting Medicare

5 Chiropractors found. Showing 1 - 5

Dr. Patrick Alan Hickman, DC Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 400 East Lakeshore Drive, Ashland, WI 54806 Phone: 715-682-5656    Fax: 715-682-5225

Christopher Craig Gilbaugh, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 1022 Lake Shore Dr E, Ashland, WI 54806 Phone: 715-682-5333

Chiropractic Clinic Sc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1219 Main St W, Ashland, WI 54806 Phone: 715-682-4033    Fax: 715-682-4033

Hickman Chiropractic, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 400 East Lakeshore Drive, Ashland, WI 54806 Phone: 715-682-5656    Fax: 715-682-5225

Richard Dale Glessing, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1219 Main St W, Ashland, WI 54806 Phone: 715-682-4033    Fax: 715-682-4033

News Archive

Study evaluates course of PTSD after diagnosis of breast cancer

A study by researchers at the Herbert Irving Comprehensive Cancer Center (HICCC) at NewYork-Presbyterian/Columbia University Medical Center, has found that nearly one in four women (23 percent) newly diagnosed with breast cancer reported symptoms consistent with post-traumatic stress disorder (PTSD) shortly after diagnosis, with increased risk among black and Asian women.

New class of targeted cancer drugs may prove effective in treating common types of leukemia

A new study by researchers in Cleveland Clinic's Taussig Cancer Institute and Lerner Research Institute describes a novel class of targeted cancer drugs that may prove effective in treating certain common types of leukemia.

Genomics study shows multiple and diverse SARS-CoV-2 introductions in the US capital region

A recent study led by the researchers from Johns Hopkins University reveals multiple and diverse introductions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the United States National Capital Region during the initial phase of coronavirus disease 2019 (COVID-19) pandemic. The study is currently available on the medRxiv* preprint server.

FDA advisory panel votes in favor of NovoTTF-100A System for supra-tentorial glioblastoma multiforme tumors

Novocure announced today that the U.S. Food and Drug Administration (FDA) Neurological Devices Advisory Panel of the Medical Devices Advisory Committee voted (7 yes; 3 no; 2 abstain) that for patients with supra-tentorial glioblastoma multiforme (GBM) tumors that recur after maximal surgical and radiation treatments, there is reasonable assurance that the benefits of the NovoTTF-100A System (NovoTTF) outweigh its risks when administered as a monotherapy in place of standard medical therapy.

Read more Medical News

› Verified 8 days ago